How Sales Leaders Build Territories Around Access, Not Just Account Lists

A clean account list gives sales leaders a false sense of control. It looks complete. It ranks neatly by volume. It fits on one slide. But the list says nothing about whether a rep can actually walk into those accounts, hold a meaningful conversation, and influence a buying decision.

In healthcare, a high procedure volume at an account means nothing if the rep assigned to it cannot get past the front desk, past the credentialing requirement, or past the IDN’s vendor policy. The accounts on the list and the accounts a rep can actually work are two different sets, and the revenue that falls between them is rarely counted or recovered.

The access problem is structural and has been worsening for over a decade. Physician employment has shifted from mostly independent to mostly system-employed. Vendor credentialing has become a formal operational layer, and Value Analysis Committees have moved purchasing authority away from individual clinicians. And health systems have consolidated at a pace that gives a single administrator the power to restrict access across dozens of affiliated sites simultaneously. Each of these shifts compounds the others.

Veeva’s analysis of over 600 million HCP interactions found that only 45% of healthcare professionals are accessible to biopharmas, with half restricting engagement to three or fewer companies.

In specialties like internal medicine, oncology, psychiatry, and urology, nearly 30% of physicians in those specialties restrict access to just one company. A territory built from volume data alone will send reps straight into those walls.

This article breaks down how healthcare sales leaders are re-engineering territory design around access, rather than lists. It covers what access really means in a consolidated market, why list-based models underperform, how to separate accessible from restricted accounts, and how tools let teams build territories reps can actually execute.

The Gap Between Account Lists and Real Access

Most healthcare territory plans start the same way. A sales ops team pulls a roster of target accounts, ranks them by procedure volume or prescribing potential, drops them onto a map, and assigns reps.

The logic is clean on paper. The problem is that the roster assumes every high-volume account is a real opportunity. But in reality, a large share of those accounts are sealed off by policies the rep cannot influence.

ZS’s long-running AccessMonitor data, which aggregates call records from a majority of U.S. pharmaceutical reps, shows that 53% of U.S. physicians place moderate-to-severe restrictions on sales rep visits, up from just 23% in 2008.

The decline cuts across specialties that used to be rep-friendly, including oncology, where 73% of oncologists are now labeled access-restricted.

The shift in physician employment is the biggest single driver. Roughly 70% of U.S. physicians are now employed by hospitals, health systems, or corporate entities, which means the access rules are set at the system level, not by the individual clinician.

A surgeon who would happily meet a rep in 2014 now sits within an IDN with a blanket visitor policy, a credentialing requirement, and a Value Analysis Committee that controls what gets put under contract.

So a rep can drive to an account that looks perfect on the map, check in through Reptrax, wait in a lobby, and still never see the surgeon. The account is on the list, but the access is not.

What “Access” Means in Healthcare Sales

Access in healthcare sales is not a single gate. It is a stack of conditions that must all align before a rep can move a deal forward. Treating access as a binary attribute of an account is part of why list-based territory plans fail.

In reality, access sits on a spectrum. The industry already recognizes sub-categories within this, “no-see” HCPs who restrict or completely deny access to reps, and “low-see” HCPs who may not shut reps out entirely but have significantly reduced interaction frequency, meeting only under specific conditions or much less frequently than before.

Physical Access to the Facility

Hospitals and health systems enforce vendor credentialing through services like Reptrax, Vendormate, and Symplr.

Reps without current immunizations, HIPAA training, background checks, and facility-specific approvals are turned away at the door, regardless of whether a surgeon is waiting.

The operational weight of this is significant. GHX internal data shows the average med-device company spends roughly 21,358 hours per year on credentialing across administrative, HR, and sales departments.

For a territory plan, that means every account inside a credentialed facility carries a real-time tax before a single sales conversation happens.

Policy Access at the System Level

Some IDNs operate highly restricted access policies that effectively bar pharma reps from engaging clinicians directly. Kaiser Permanente is the most documented example. Kaiser Permanente’s medical groups have chosen to significantly restrict direct-to-clinician marketing by pharmaceutical sales representatives, with pharmacist drug education coordinators providing prescribers with unbiased information on medications instead.

Other large systems have moved in the same direction. The pattern accelerated after 2009, when the Physician Payments Sunshine Act introduced federal disclosure requirements around industry-physician financial relationships, giving health systems a compliance rationale to formalise vendor access restrictions that had previously been informal.

A rep who doesn’t know which category a system falls into before planning their week is working from an incomplete map.

The research firm HIRC shows just how structured this control has become. 88% of IDNs maintain an inpatient formulary, 75% enforce standardized treatment pathways, and IDNs embed order sets and best-practice alerts into the EMR to enforce compliance.

Any product outside those pathways faces a structural headwind that the rep cannot solve on-site.

Decision-Maker Access

Even when a rep is inside the building, the person who decides whether to buy is rarely the physician alone. Value Analysis Committees, which include clinicians, administrators, finance leads, and supply chain managers, now gate most MedTech purchasing decisions.

As a MedTech practice notes, the VAC determines product value, controls the product formulary, and enforces clinician compliance with that formulary. A surgeon who champions a device has influence, not only authority.

Cognitive and Time Access

The final layer is the scarcest, which is the clinician’s attention. Veeva’s engagement data shows that half of accessible HCPs now meet with three or fewer companies, and content is shared in fewer than half of all customer interactions.

The rep who gets five minutes with a surgeon is competing with every other rep, every EHR alert, and every patient in the waiting room. Access without a reason to engage collapses into a wasted slot.

Why Access-Driven Territories Outperform List-Based Models

List-based territory models optimize for a number that’s easy to defend in a QBR, the total addressable volume. Access-driven models optimize for what actually moves the number on the revenue line, which is reachable volume.

The two overlap less than most sales leaders assume.

One concrete example is a Commercial Summit case study, where a biopharma that layered industry-wide access data onto its existing prescriber file uncovered 7,000 new HCP targets, with 100 of those showing both high prescribing potential and high access, translating into a projected $72 million in annual revenue.

Those HCPs existed in the market the entire time. The old list-based segmentation simply didn’t know who among the high-potential set was actually reachable.

The operational case is equally direct. BCG’s November 2025 research on MedTech shows companies under pressure to cut 7% to 12% from their total cost baseline, with procurement-led transformation as the starting point and gross margin gains of up to three points.

That cost discipline extends into commercial operations, where a territory plan that sends reps to unreachable accounts is exactly the kind of inefficient spend finance teams are now mandated to remove.

Identifying Accessible vs Restricted Accounts

The first step in access-driven territory design is scoring every account on two independent axes: clinical opportunity and access viability.

For clinical opportunity, teams pull procedure-level billing data like CPT, HCPCS, and ICD-10 codes filtered to the specific indications or devices in scope. This gives a volume-based rank for each provider based on actual documented activity, not specialty assumptions.

For access viability, teams layer in several signals simultaneously, like the provider’s employment status (independent vs. system-employed), their IDN or hospital affiliation, and that system’s known vendor policy, whether the facility requires credentialing, and any available engagement history showing whether reps have successfully reached that account before.

The scoring is not a one-time exercise. Access viability changes as systems consolidate, affiliation data updates occur, and credentialing statuses shift, which is why the segmentation needs to be refreshed regularly, not annually.

Layering Procedure Data with System Affiliation

Raw CPT and HCPCS volume tells you where the clinical opportunity is. Adding hospital and IDN affiliation tells you who controls access to that opportunity.

A surgeon billing 400 spine procedures a year looks identical to another on a volume map, but if one is inside an IDN with a preferred-vendor contract against your device and the other is in a physician-owned group, the two accounts are not the same territory problem.

Definitive Healthcare’s IDN research puts the scale of this into context. More than 80% of U.S. hospitals are now part of an IDN. That means for most territories, the starting assumption should be that access is conditioned on system-level policies, not individual physician preference.

Segmenting by Control Continuum

A useful framework from an IDN strategy is to segment health systems by their Control Continuum, ranging from “Low Control” loose affiliations, where individual hospitals retain purchasing power, to “High Control” systems with a single strict formulary and consequences for non-compliance. Territory strategy should shift accordingly.

In low-control systems, individual surgeon relationships still drive most of the outcome. In high-control systems, a win at the VAC unlocks volume across dozens of sites, a loss at the VAC means the list of affiliated surgeons is effectively dead inventory, no matter how many calls the rep makes.

Using Real Engagement Data, Not Directory Tags

Specialty directories and taxonomy codes are a weak proxy for real access. A study by JAMA Network shows that directory fields are wrong or inconsistent for roughly 80% of the physicians listed.

Recent claims data, referral patterns, and documented engagement history give a far more honest picture of which providers are currently active, who they share patients with, and which sites of care they actually work from week to week.

Designing Territories That Reps Can Execute

Once access signals are layered into the segmentation, territory design becomes a different exercise. The goal shifts from covering the map to loading each rep with the maximum number of opportunities they can physically and cognitively handle in a week.

Balancing Reachable Volume, Not Total Volume

PharmExec’s analysis of pharma sales force effectiveness makes the point directly: physicians find only one-third of sales calls valuable, more than 20% restrict access to reps, and nearly 90% of interactions last less than two minutes.

When quotas are built on total prescribing volume rather than reachable volume, those numbers get worse, and reps assigned to access-restricted accounts exhaust their weeks on accounts that will never convert, while reps in more open markets appear to overperform on the same metric. Neither reading reflects actual rep performance. Both are artifacts of a territory design that ignored access at the start.

Accounting for Physical Coverage Math

Access is not only about policy. It is also about hours in the day. PharmExec’s long-running MSL survey found that field medical teams work 46 to 50 hours per week on average, with roughly a third reporting being away from home two nights per week.

Sales rep coverage patterns in MedTech look similar. A territory that looks efficient on paper collapses when drive times, OR schedules, and credentialing queues are added to the calendar. Access-driven territory design treats drive radius and daily call capacity as hard constraints, not footnotes.

Building In the VAC and KAM Layer

For biopharma teams selling into consolidated health systems, the territory is no longer only a set of prescribers. It is a set of decision units.

Accenture estimates that more than half of all physician group practices are owned by large healthcare organisations, where physicians don’t have the final say in treatment protocols, which means the rep calling on the physician is often working one level below where the real decision is made.

A modern territory plan assigns a field rep to reachable physicians within a drive radius, and a KAM to the system-level committees that influence those physicians’ buying decisions. The two roles are coordinated and not duplicated.

From Access Insights to Field Execution

The best segmentation only pays off if the rep in the field can act on it. This is where a lot of access-aware territory plans still don’t work out. Ops teams build a clean, access-weighted segmentation in a spreadsheet, and reps continue to run the same call list they used last quarter because nothing has changed in their CRM.
Veeva’s 2025 Pulse analysis flags this execution gap bluntly that field teams leverage content in fewer than half of HCP meetings, and nearly 80% of approved content is rarely or never used. When reps do not have the right message pre-loaded for the right access context, even a well-designed territory degrades into generic detailing.

Three operational moves close that gap.

Put Access Scores in the CRM

First, access scores should live inside the CRM record. A rep looking at an account should see, at a glance, whether the facility is open-access, restricted, or closed, and where that classification comes from matters.

Open-access status can be drawn from credentialing platform data (if a rep has completed Reptrax or Symplr requirements for that site, the facility has a defined access path). Restricted or closed status can be inferred from IDN affiliation records cross-referenced against known vendor policy databases, engagement history showing repeated failed access attempts, or system-level procurement data indicating a GPO or formulary contract that excludes the product.

For decision-maker structure, whether authority sits with the clinician, a VAC, or a system-level committee, the signal comes from IDN Control Continuum classification, that is, high-control systems almost always route purchasing through a committee, while low-control affiliations leave more authority with the individual physician.

Refresh Territory Priorities Often

Alpha Sophia’s commercial research points to a neurology team that kept revenue flat while cutting the sales force by 67% and saving more than $15 million, simply by recalculating territory priorities every 30 days rather than once a year.

Also, every call plan should carry a specific access-aware next step, whether that’s a credentialing update, a VAC engagement, or a clinical evidence share.

Reserve In-Person Time for Accounts Where Access Actually Converts

In-person time remains the most valuable and the most constrained resource. Veeva’s 2024 research showed that oncologists who engaged through a combination of in-person and video averaged 11 meetings per month with pharma, versus 4.5 for those who met only in person.

Access-driven execution uses the channel mix deliberately with field visits reserved for accounts where a rep can meaningfully influence a clinical or committee decision, and virtual or digital touchpoints layered in everywhere else.

How Alpha Sophia Enables Access-Driven Territory Planning

Building access-driven territories at scale needs a few things in one place:

• Granular clinical data on each provider
• Who they’re affiliated with
• A way to design and adjust territories without an eight-week analyst cycle

Alpha Sophia is built around that combination.

CPT, HCPCS, and ICD-10 Filtering at the Provider Level

Alpha Sophia gives sales teams direct access to procedure-level and diagnosis-level billing data across Medicare, Medicaid, government, and commercial payors, covering roughly 80% of U.S. medical claims.

Instead of ranking physicians by specialty tags, teams can filter by the exact CPT, HCPCS, and ICD-10 codes that match their device or therapy.

A territory becomes a set of providers performing the specific procedures or treating the specific diagnoses for which a product is built, rather than a generic specialty roster.

Affiliation, Site of Care, and Geographic Layering

Every provider profile in Alpha Sophia carries their practice locations, hospital and system affiliations, and site-of-care details. That lets sales ops teams separate physicians who bill high volumes inside a closed IDN from physicians who operate in more accessible outpatient settings, ambulatory surgery centers, or independent groups.

The platform’s Territory Manager builds, manages, and edits territories nationwide and uses driving-distance calculations to match providers and organizations to reps based on realistic field coverage, not radius circles on a map.

Cohort Analysis and Dynamic Refresh

The cohort analysis feature lets teams compare groups of providers side by side, looking for shifts in procedure mix, diagnosis patterns, or affiliation changes over time.

As IDN ownership shifts and new access restrictions come online, territory design has to move with them. This is what traditional annual planning cycles cannot deliver and is exactly the kind of refresh cadence that access-driven territory plans depend on.

CRM and API Integration

Access insights only change field behavior if they land in the tools reps already use. Alpha Sophia integrates directly with Salesforce, HubSpot, and exposes its healthcare provider data through an API that companies can feed into their own systems.

That means the access score on an account, the system affiliation, and the decision-maker layer can live alongside every call note the rep writes, instead of in a separate planning file.

Conclusion

Account lists are not the problem, but treating them as finished territory plans is. In a market where access to HCPs has been in structural decline for more than a decade and 70% of physicians are employed by systems that set the access rules, volume on its own is a misleading signal.

The territories that outperform in 2026 are the ones built around reachable opportunity with providers whose procedure mix fits the product, whose facilities the rep can physically enter, whose decision-makers are identifiable, and whose time can actually be earned.

That design requires real clinical data, real affiliation data, and a territory tool that moves as fast as the market does. Alpha Sophia puts those three ingredients in one place, so that the territory a sales leader hands to a rep is not only a list, but a plan the rep can execute.

FAQs

What does access mean in healthcare sales?
Access in healthcare sales is the set of conditions that determine whether a rep can actually engage a provider and influence a buying decision. It includes physical access to the facility, policy-level rules set by hospitals or IDNs, the decision-maker structure around the physician, and the provider’s available time and attention. A high-volume account with no access path is not a real sales opportunity.

Why are some healthcare providers difficult to reach?
Most U.S. physicians are now employed by hospitals or health systems that set vendor access policies centrally. Credentialing requirements, restricted visitor policies, and Value Analysis Committees mean the individual clinician often cannot decide who to meet with or what to buy. On top of that, packed clinical schedules leave very little unstructured time for sales conversations.

How does access impact sales performance?
Access directly determines how much of a territory’s nominal volume a rep can convert. When reps are assigned to accounts they cannot enter or influence, call productivity drops, sales cycles lengthen, and territories with similar volume profiles show very different conversion rates. Access-aware territories typically show better rep productivity and more predictable quota attainment.

Why do account lists fail without access insights?
Account lists ranked only by volume or prescribing potential treat every high-potential provider as equally reachable. In reality, access varies sharply by system affiliation, specialty, and geography. Without an access layer, list-based territories load reps with accounts that look strong on paper but are gated by closed-door policies, formulary restrictions, or committee decisions that the rep cannot influence on a field visit.

What factors influence provider accessibility?
The main drivers are employment status (employed vs. independent), IDN or health system affiliation, facility-level vendor credentialing policies, VAC or formulary control, specialty norms, and the provider’s personal engagement preferences across in-person, video, and digital channels. Each of these can change quarter to quarter as systems consolidate, merge, or update their vendor policies.

How can sales leaders design more executable territories?
By scoring accounts on both clinical opportunity and access, aligning territory boundaries to realistic field coverage and decision units, separating field rep and KAM responsibilities in consolidated systems, and refreshing territory assignments on a quarterly cadence using live claims and affiliation data. Tools like Alpha Sophia make that workflow operational by combining CPT, HCPCS, and ICD-10 filtering with affiliation data, driving-distance territory design, and direct CRM integration.